473 related articles for article (PubMed ID: 30007826)
1. Effects of geographic and economic heterogeneity on the burden of rotavirus diarrhea and the impact and cost-effectiveness of vaccination in Pakistan.
Rheingans R; Anderson JD; Bagamian KH; Laytner LA; Pecenka CJ; Gilani SSA; Ahmed M
Vaccine; 2018 Dec; 36(51):7780-7789. PubMed ID: 30007826
[TBL] [Abstract][Full Text] [Related]
2. Effects of geographic and economic heterogeneity on rotavirus diarrhea burden and vaccination impact and cost-effectiveness in the Lao People's Democratic Republic.
Rheingans R; Anderson JD; Bagamian KH; Pecenka CJ
Vaccine; 2018 Dec; 36(51):7868-7877. PubMed ID: 30007827
[TBL] [Abstract][Full Text] [Related]
3. Estimated impact and cost-effectiveness of rotavirus vaccination in India: effects of geographic and economic disparities.
Rheingans R; Anderson JD; Anderson B; Chakraborty P; Atherly D; Pindolia D
Vaccine; 2014 Aug; 32 Suppl 1():A140-50. PubMed ID: 25091669
[TBL] [Abstract][Full Text] [Related]
4. Effects of geographic and economic heterogeneity on the burden of rotavirus diarrhea and the impact and cost-effectiveness of vaccination in Nigeria.
Anderson JD; Pecenka CJ; Bagamian KH; Rheingans RD
PLoS One; 2020; 15(5):e0232941. PubMed ID: 32469927
[TBL] [Abstract][Full Text] [Related]
5. Distributional impact of rotavirus vaccination in 25 GAVI countries: estimating disparities in benefits and cost-effectiveness.
Rheingans R; Atherly D; Anderson J
Vaccine; 2012 Apr; 30 Suppl 1():A15-23. PubMed ID: 22520124
[TBL] [Abstract][Full Text] [Related]
6. Cost-effectiveness of a new rotavirus vaccination program in Pakistan: a decision tree model.
Patel HD; Roberts ET; Constenla DO
Vaccine; 2013 Dec; 31(51):6072-8. PubMed ID: 24176497
[TBL] [Abstract][Full Text] [Related]
7. Cost-effectiveness analysis of rotavirus vaccination in Argentina.
Urueña A; Pippo T; Betelu MS; Virgilio F; Hernández L; Giglio N; Gentile Á; Diosque M; Vizzotti C
Vaccine; 2015 May; 33 Suppl 1():A126-34. PubMed ID: 25919152
[TBL] [Abstract][Full Text] [Related]
8. Cost-effectiveness of rotavirus vaccination in Ghana: Examining impacts from 2012 to 2031.
Nonvignon J; Atherly D; Pecenka C; Aikins M; Gazley L; Groman D; Narh CT; Armah G
Vaccine; 2018 Nov; 36(47):7215-7221. PubMed ID: 29223486
[TBL] [Abstract][Full Text] [Related]
9. Projected health and economic impact of rotavirus vaccination in GAVI-eligible countries: 2011-2030.
Atherly DE; Lewis KD; Tate J; Parashar UD; Rheingans RD
Vaccine; 2012 Apr; 30 Suppl 1():A7-14. PubMed ID: 22520139
[TBL] [Abstract][Full Text] [Related]
10. Analysis of the Universal Immunization Programme and introduction of a rotavirus vaccine in India with IndiaSim.
Megiddo I; Colson AR; Nandi A; Chatterjee S; Prinja S; Khera A; Laxminarayan R
Vaccine; 2014 Aug; 32 Suppl 1():A151-61. PubMed ID: 25091670
[TBL] [Abstract][Full Text] [Related]
11. Cost-Effectiveness of Monovalent Rotavirus Vaccination of Infants in Malawi: A Postintroduction Analysis Using Individual Patient-Level Costing Data.
Bar-Zeev N; Tate JE; Pecenka C; Chikafa J; Mvula H; Wachepa R; Mwansambo C; Mhango T; Chirwa G; Crampin AC; Parashar UD; Costello A; Heyderman RS; French N; Atherly D; Cunliffe NA;
Clin Infect Dis; 2016 May; 62 Suppl 2(Suppl 2):S220-8. PubMed ID: 27059360
[TBL] [Abstract][Full Text] [Related]
12. Estimated impact and cost-effectiveness of rotavirus vaccination in Senegal: A country-led analysis.
Diop A; Atherly D; Faye A; Lamine Sall F; Clark AD; Nadiel L; Yade B; Ndiaye M; Fafa Cissé M; Ba M
Vaccine; 2015 May; 33 Suppl 1():A119-25. PubMed ID: 25919151
[TBL] [Abstract][Full Text] [Related]
13. Cost-effectiveness analysis of rotavirus vaccination among Libyan children using a simple economic model.
Alkoshi S; Maimaiti N; Dahlui M
Libyan J Med; 2014; 9(1):26236. PubMed ID: 25499622
[TBL] [Abstract][Full Text] [Related]
14. Economic costs of rotavirus gastroenteritis and cost-effectiveness of vaccination in developing countries.
Rheingans RD; Antil L; Dreibelbis R; Podewils LJ; Bresee JS; Parashar UD
J Infect Dis; 2009 Nov; 200 Suppl 1():S16-27. PubMed ID: 19817595
[TBL] [Abstract][Full Text] [Related]
15. Public finance of rotavirus vaccination in India and Ethiopia: an extended cost-effectiveness analysis.
Verguet S; Murphy S; Anderson B; Johansson KA; Glass R; Rheingans R
Vaccine; 2013 Oct; 31(42):4902-10. PubMed ID: 23871824
[TBL] [Abstract][Full Text] [Related]
16. Projected cost-effectiveness of rotavirus vaccination for children in Asia.
Podewils LJ; Antil L; Hummelman E; Bresee J; Parashar UD; Rheingans R
J Infect Dis; 2005 Sep; 192 Suppl 1():S133-45. PubMed ID: 16088797
[TBL] [Abstract][Full Text] [Related]
17. Cost-effectiveness of rotavirus vaccination in Kenya and Uganda.
Sigei C; Odaga J; Mvundura M; Madrid Y; Clark AD; ;
Vaccine; 2015 May; 33 Suppl 1():A109-18. PubMed ID: 25919149
[TBL] [Abstract][Full Text] [Related]
18. Health care costs of diarrheal disease and estimates of the cost-effectiveness of rotavirus vaccination in Vietnam.
Fischer TK; Anh DD; Antil L; Cat ND; Kilgore PE; Thiem VD; Rheingans R; Tho le H; Glass RI; Bresee JS
J Infect Dis; 2005 Nov; 192(10):1720-6. PubMed ID: 16235169
[TBL] [Abstract][Full Text] [Related]
19. Costs of diarrheal disease and the cost-effectiveness of a rotavirus vaccination program in kyrgyzstan.
Flem ET; Latipov R; Nurmatov ZS; Xue Y; Kasymbekova KT; Rheingans RD
J Infect Dis; 2009 Nov; 200 Suppl 1():S195-202. PubMed ID: 19817600
[TBL] [Abstract][Full Text] [Related]
20. Cost-effectiveness analysis of the introduction of rotavirus vaccine in Iran.
Javanbakht M; Moradi-Lakeh M; Yaghoubi M; Esteghamati A; Mansour Ghanaie R; Mahmoudi S; Shamshiri AR; Zahraei SM; Baxter L; Shakerian S; Chaudhri I; Fleming JA; Munier A; Baradaran HR
Vaccine; 2015 May; 33 Suppl 1():A192-200. PubMed ID: 25919160
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
